Spots Global Cancer Trial Database for A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
Official Title: A Phase II Single Arm Clinical Trial of Nivolumab (BMS-936558) in Subjects With Metastatic or Unresectable Urothelial Cancer Who Have Progressed or Recurred Following Treatment With a Platinum Agent
Study ID: NCT02387996
Conditions
Interventions
Study Description
Brief Summary: The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0013, Phoenix, Arizona, United States
Local Institution - 0012, Duarte, California, United States
Pacific Hematology Oncology Associates, San Francisco, California, United States
Local Institution - 0016, Aurora, Colorado, United States
University Cancer Blood Ctr, Athens, Georgia, United States
Ft. Wayne Med Onco-Hema Inc, Fort Wayne, Indiana, United States
Local Institution - 0030, Indianapolis, Indiana, United States
Local Institution - 0052, Iowa City, Iowa, United States
Crescent City Research Consortium, LLC, Marrero, Louisiana, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
GU Research Network, LLC, Omaha, Nebraska, United States
Local Institution - 0028, New York, New York, United States
Local Institution - 0004, Charlotte, North Carolina, United States
Local Institution - 0051, Portland, Oregon, United States
Local Institution - 0029, Philadelphia, Pennsylvania, United States
Local Institution - 0059, Pittsburgh, Pennsylvania, United States
Erlanger Oncology & Hematology - Univ. of TN, Chattanooga, Tennessee, United States
Local Institution - 0001, Houston, Texas, United States
Local Institution - 0036, Seattle, Washington, United States
Local Institution - 0060, Waratah, New South Wales, Australia
Local Institution - 0070, Elizabeth Vale, South Australia, Australia
Local Institution - 0022, Brussels, , Belgium
Local Institution - 0023, Edegem, , Belgium
Local Institution - 0024, Hasselt, , Belgium
Local Institution - 0027, Brno, , Czechia
Local Institution - 0026, Olomouc, , Czechia
Local Institution, Praha 5, , Czechia
Local Institution - 0010, Helsinki, , Finland
Local Institution - 0009, Tampere, , Finland
Local Institution - 0049, Erfurt, , Germany
Local Institution - 0047, Erlangen, , Germany
Local Institution - 0042, Hamburg, , Germany
Local Institution - 0043, Heidelberg, , Germany
Local Institution - 0015, Jena, , Germany
Local Institution - 0041, Muenchen, , Germany
Local Institution, Rostock, , Germany
Local Institution - 0048, Tuebingen, , Germany
Local Institution - 0017, Arezzo, , Italy
Local Institution - 0020, Milano, , Italy
Local Institution - 0018, Napoli, , Italy
Local Institution - 0050, Pavia, , Italy
Local Institution - 0021, Roma, , Italy
Local Institution - 0074, Akita-shi, Akita, Japan
Local Institution - 0083, Hirosaki-shi, Aomori, Japan
Local Institution - 0081, Tsukuba-shi, Ibaraki, Japan
Local Institution - 0078, Morioka-shi, Iwate, Japan
Local Institution, Yokohama, Kanagawa, Japan
Local Institution - 0080, Kumamoto-shi, Kumamoto, Japan
Local Institution - 0082, Kyoto-shi, Kyoto, Japan
Local Institution - 0076, Niigata-shi, Niigata, Japan
Local Institution - 0084, Osaka-Sayama-Shi, Osaka, Japan
Local Institution - 0085, Bunkyo-ku, Tokyo, Japan
Local Institution - 0073, Bunkyo-ku, Tokyo, Japan
Local Institution - 0077, Bunkyo-ku, Tokyo, Japan
Local Institution - 0086, Shinjuku-ku, Tokyo, Japan
Local Institution - 0075, Shinjuku-ku, Tokyo, Japan
Local Institution, Gdansk, , Poland
Local Institution - 0046, Krakow, , Poland
Local Institution - 0040, Lodz, , Poland
Local Institution - 0056, Szczecin, , Poland
Local Institution - 0038, Wroclaw, , Poland
Local Institution - 0035, Badalona-barcelona, , Spain
Local Institution - 0033, Barcelona, , Spain
Local Institution - 0034, Hospitalet de Llobregat - Barcelona, , Spain
Local Institution - 0031, Madrid, , Spain
Local Institution - 0032, Sevilla, , Spain
Local Institution - 0014, Lund, , Sweden
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
